Window-of-opportunity Study Testing the Antiproliferative Effect of Atorvastatin in Egyptian Patients with Operable Breast Cancer

Bader A. Abdelmaksoud; Mohamed I. Abdelhamid; Salah Abd Elaal; Hayam E. Rashed

doi:10.13189/cor.2017.050401

Window-of-opportunity Study Testing the Antiproliferative Effect of Atorvastatin in Egyptian Patients with Operable Breast Cancer

Cancer and Oncology Research ◽

10.13189/cor.2017.050401 ◽

2017 ◽

Vol 5 (4) ◽

pp. 53-59

Author(s):

Bader A. Abdelmaksoud ◽

Mohamed I. Abdelhamid ◽

Salah Abd Elaal ◽

Hayam E. Rashed

Keyword(s):

Breast Cancer ◽

Operable Breast Cancer ◽

Antiproliferative Effect ◽

Window Of Opportunity ◽

Egyptian Patients

Download Full-text

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-015-3307-5 ◽

2015 ◽

Vol 150 (1) ◽

pp. 149-155 ◽

Cited By ~ 46

Author(s):

Sirwan M. Hadad ◽

Philip Coates ◽

Lee B. Jordan ◽

Ryan J. O. Dowling ◽

Martin C. Chang ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Biological Effects ◽

Cancer Biomarker ◽

Operable Breast Cancer ◽

Window Of Opportunity ◽

Biomarker Analysis

Download Full-text

Abstract OT2-6-06: Pre-surgical “window of opportunity” trial of metformin and atorvastatin in newly diagnosed operable breast cancer

10.1158/0008-5472.sabcs13-ot2-6-06 ◽

2013 ◽

Author(s):

K Kalinsky ◽

L Baer ◽

WY Tsai ◽

MC Ngan ◽

SM Feldman ◽

...

Keyword(s):

Breast Cancer ◽

Operable Breast Cancer ◽

Window Of Opportunity ◽

Newly Diagnosed

Download Full-text

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1612-1 ◽

2011 ◽

Vol 128 (3) ◽

pp. 783-794 ◽

Cited By ~ 191

Author(s):

Sirwan Hadad ◽

Takayuki Iwamoto ◽

Lee Jordan ◽

Colin Purdie ◽

Susan Bray ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Biological Effects ◽

Operable Breast Cancer ◽

Window Of Opportunity

Download Full-text

VENTANA (SOLTI-1501): Antiproliferative effect of the addition of oral metronomic vinorelbine to endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial

Annals of Oncology ◽

10.1093/annonc/mdx362.063 ◽

2017 ◽

Vol 28 ◽

pp. v66

Author(s):

B. Adamo ◽

J.A. Perez Fidalgo ◽

E. Ciruelos ◽

M. Vidal ◽

S. Blanch ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Antiproliferative Effect ◽

Window Of Opportunity ◽

Metronomic Vinorelbine

Download Full-text

Abstract S2-03: Preoperative window of opportunity study of the PI3K inhibitor pictilisib (GDC-0941) plus anastrozole vs anastrozole alone in patients with ER+, HER2-negative operable breast cancer (OPPORTUNE study)

10.1158/1538-7445.sabcs14-s2-03 ◽

2015 ◽

Cited By ~ 1

Author(s):

Peter Schmid ◽

Sarah E Pinder ◽

Duncan Wheatley ◽

Jane Macaskill ◽

Charles Zammit ◽

...

Keyword(s):

Breast Cancer ◽

Operable Breast Cancer ◽

Pi3k Inhibitor ◽

Window Of Opportunity

Download Full-text

Value of detection of bone marrow (BM) micrometastases by quantitative real-time RT-PCR in primary operable breast cancer(BC)

European Journal of Cancer ◽

10.1016/s0959-8049(02)80348-3 ◽

2002 ◽

Vol 38 (11) ◽

pp. S108-S109

Author(s):

M Saad Ismail

Keyword(s):

Breast Cancer ◽

Bone Marrow ◽

Real Time ◽

Operable Breast Cancer ◽

Rt Pcr ◽

Primary Operable Breast Cancer

Download Full-text

Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80298-2 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

I Svane

Keyword(s):

Breast Cancer ◽

High Risk ◽

Late Toxicity ◽

High Dose Chemotherapy ◽

Operable Breast Cancer ◽

High Dose ◽

Primary Operable Breast Cancer

Download Full-text

Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70039-3 ◽

2006 ◽

Vol 2006 ◽

pp. 57-58

Author(s):

M. Morrow

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Adjuvant Chemotherapy ◽

Randomized Clinical Trials ◽

Operable Breast Cancer ◽

National Surgical Adjuvant Breast ◽

Locoregional Failure ◽

Bowel Project

Download Full-text

Faculty Opinions recommendation of Neoadjuvant talazoparib (TALA) for operable breast cancer patients with a BRCA mutation (BRCA+).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736215357.793562858 ◽

2019 ◽

Author(s):

Sherene Loi

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Brca Mutation ◽

Operable Breast Cancer ◽

Breast Cancer Patients

Download Full-text

Clinical Significance of Microscopic Metastases in Axillary Lymph Nodes in Primary Operable Breast Cancer. (Literature Review)

Journal of Ural Medical Academic Science ◽

10.22138/2500-0918-2018-15-1-116-123 ◽

2018 ◽

Vol 15 (1) ◽

pp. 116-123

Author(s):

V.E. Ponomarev ◽

◽

J.V. Vishnevskaja ◽

N.I. Mehtieva ◽

S.B. Polikarpova ◽

...

Keyword(s):

Breast Cancer ◽

Literature Review ◽

Lymph Nodes ◽

Clinical Significance ◽

Operable Breast Cancer ◽

Axillary Lymph Nodes ◽

Axillary Lymph ◽

Primary Operable Breast Cancer

Download Full-text